A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy

Clinical trial NCT05942508 · UNKNOWN

Trial details

NCT number: NCT05942508
Sponsor: Jinming Yu
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Limited Stage Small Cell Lung Cancer Not Progressed After First-line Chemoradiotherapy

Start date: 2023-05-30
Primary completion: 2026-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.